Cite
HARVARD Citation
Ciresi, A. et al. (n.d.). Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. Clinical endocrinology. pp. 845-852. [Online].